<生产厂家价格>

S-(2-羟基-5-硝基苄基)-6-硫代肌苷

S-(2-羟基-5-硝基苄基)-6-硫代肌苷名称

[ CAS 号 ]:
56964-73-9

[ 中文名 ]:
S-(2-羟基-5-硝基苄基)-6-硫肌苷

[ 英文名 ]:
S-(2-HYDROXY-5-NITROBENZYL)-6-THIOINOSINE

[英文别名 ]:

S-(2-羟基-5-硝基苄基)-6-硫代肌苷物理化学性质

[ 密度 ]:
1.87g/cm3

[ 沸点 ]:
829.7ºC at 760mmHg

[ 分子式 ]:
C₁₇H₁₇N₅O₇S

[ 分子量 ]:
435.41100

[ 闪点 ]:
455.6ºC

[ 精确质量 ]:
435.08500

[ PSA ]:
204.87000

[ LogP ]:
0.86710

[ 折射率 ]:
1.83

S-(2-羟基-5-硝基苄基)-6-硫代肌苷MSDS

详细MSDS(安全技术说明书)

S-(2-羟基-5-硝基苄基)-6-硫代肌苷安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xi

[ 风险声明 (欧洲) ]:
36/37/38

[ 安全声明 (欧洲) ]:
26-36

[ 危险品运输编码 ]:
NONH for all modes of transport

S-(2-羟基-5-硝基苄基)-6-硫代肌苷文献

Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.

Bioorg. Med. Chem. 16 , 3848-65, (2008)

Conformationally constrained analogue synthesis was undertaken to aid in pharmacophore mapping and 3D-QSAR analysis of nitrobenzylmercaptopurine riboside (NBMPR) congeners as equilibriative nucleoside...

Inhibitors of nucleoside transport. A structure-activity study using human erythrocytes.

J. Med. Chem. 18 , 968, (1975)

The passage of nucleosides across the plasma membrane of erythrocytes is a membrane-mediated process which is strongly inhibited by derivatives of 9-beta-D-ribofuranosylpurine (1) with S, O, or N atom...

更多文献